SIRION Biotech

Gene Therapy Delivery Methods

This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

Siren Biotechnology

The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.

Kytopen

This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

Salve Therapeutics

The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.

CEVEC

The company produces human cell-based expression systems and viral vector manufacturing technologies for biopharmaceutical firms and biotechnology organisations developing therapeutic proteins and gene therapies.